REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)

$0.3878 -0.0288 (-6.9131%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) News Sources

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®

01-09-2026

yahoo.com

RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results

30-09-2026

yahoo.com

Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet

01-10-2026

yahoo.com

Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight

30-07-2026

yahoo.com

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

02-06-2026

yahoo.com

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo

08-06-2026

yahoo.com

RedHill Biopharma Announces Up To $19.4 Million Private Placement

18-06-2026

yahoo.com

RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

31-08-2026

yahoo.com

RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties?

10-09-2026

yahoo.com

$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma

19-10-2026

yahoo.com

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) Sentiment Trend

0 25 50 75 100 83 82 8 70 88 59 61 75 83 82 01-09-2026 30-09-2026 01-10-2026 30-07-2026 02-06-2026 08-06-2026 18-06-2026 31-08-2026 10-09-2026 19-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) FAQs

toggle

What is the current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is $0.3878.


toggle

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) absolute price change since previous trading day?

The absolute price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is $-0.0288.


toggle

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) percentage price change since previous trading day?

The percentage price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is -6.9131%.


toggle

What is the most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The most recent sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is .


SEC-8K** Filing Available For REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.